* Evaluating Drug Safety in Clinical Trials (and Observational Registries) Stuart Pocock London School of Hygiene and Tropical Medicine * Issues in Drug Safety Data Monitoring…

Dr Jonathan Day Medical Affairs Manager Nycomed UK Ltd., The Magdalen Centre, Oxford Science Park, Oxford, OX4 4GA Thrombin Specific Anticoagulation Minimising Bleeding Complications…

Ramon C. Mora M.D. Year Graduated : 1985 School : FEU-NRMF Institute of Medicine Residency : Veterans Memorial Medical Center (1987-1990) Fellowship : National Kidney &…

History of the Prothrombin Time and Development of the INR Leon Poller European Concerted Action on Anticoagulation Mean results with different thromboplastins in 30 patients…

OASIS in ACS: with Updates on 2011 ESC Guidelines on Anticoagulation Donato Maranon, MD, FPCP, FPCC, FACC Antiplatelet agents Anticoagulants Revascularization / Reperfusion…

OASIS in ACS: with Updates on 2011 ESC Guidelines on Anticoagulation Donato Maranon, MD, FPCP, FPCC, FACC Antiplatelet agents Anticoagulants Revascularization / Reperfusion…

Learning Objectives Variable Response to Clopidogrel Platelet Reactivity and Outcomes Clopidogrel Metabolism CYP450 Genetic Variants and PK/PD CYP2C19 and Clinical Outcomes…

Slide 1Stavros Apostolakis, MD, PhD University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom; Antithrombotic therapy and bleeding…

PROACT: Prospective Randomized On-X Anticoagulation Clinical Trial â Reduced Anticoagulation for a Mechanical Heart Valve John D. Puskas MD, FACS, FACC Emory University…